Reduction of the risk of PML in natalizumab treated MS patients in Sweden: An effect of improved PML risk surveillance
Author:
Funder
Biogen Inc
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference26 articles.
1. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin;Yednock;Nature,1992
2. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring;Kappos;Lancet Neurol,2011
3. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy;Plavina;Ann Neurol,2014
4. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies;Ho;Lancet Neurol,2017
5. Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time;Giovannoni;Revue Neurologique,2019
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases;Neuroimaging Clinics of North America;2024-08
2. Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification;Journal of the Neurological Sciences;2024-06
3. Lessons learned after 20 years of real-world experience with natalizumab;Multiple Sclerosis and Related Disorders;2023-12
4. Evaluation of risk management in a natalizumab home infusion procedure;Revue Neurologique;2023-10
5. Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study;Journal of Neurology;2023-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3